AMPL vs ITRN

AMPL's Piotroski F-Score of 2/9 indicates severe financial distress, with weak operational and accounting health. The absence of an Altman Z-Score and negative profitability metrics (ROE: -32.68%, ROA: -13.85%) underscore significant underlying weaknesses. Despite a 17% YoY revenue growth and strong gross margins (73.98%), the company remains unprofitable with a negative profit margin of -25.80%. Insider selling totaling $5.73M over six months and a bearish technical trend further erode confidence. The stock trades at a forward P/E of 42.85, well above the sector average, suggesting overvaluation relative to current earnings performance.

ITRN exhibits exceptional financial health with a Piotroski F-Score of 8/9, indicating strong operational efficiency and balance sheet strength. While the current price of $53.54 is a significant premium over the Graham Number ($26.84), it remains well below the growth-based intrinsic value of $67.31. The company combines steady double-digit growth with a highly attractive 11.21% dividend yield and negligible debt (D/E 0.02). Despite a bearish technical trend score and weak insider sentiment, the fundamental data suggests a high-quality compounder with significant margin of safety in its health metrics.